Literature DB >> 34191047

Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus.

Hafis Muhammed1,2, Avinash Jain1,3, Sarit Sekhar Pattanaik1, Rudrarpan Chatterjee1, R Naveen1, Hina Kabeer1, Latika Gupta1, Durga P Misra1, Vikas Agarwal1, Able Lawrence1, Ramnath Misra1, Amita Aggarwal4.   

Abstract

INTRODUCTION: There is paucity of data on tuberculosis in Indian patients with systemic lupus erythematosus (SLE). We retrospectively studied clinical features and outcome of tuberculosis in SLE.
METHODS: Medical records of patients who developed tuberculosis simultaneous or after the diagnosis of SLE were retrospectively reviewed. All patients fulfilled 1997 ACR and/or SLICC 2012 classification criteria for SLE. A diagnosis of tuberculosis required bacteriological, histopathological or CT/MRI suggestive of tuberculosis and initiation of four drug antituberculous therapy. Baseline parameters were compared with the rest of cohort to identify predictors of tuberculosis.
RESULTS: In our cohort of 1335 SLE patients, 48 (3.6%) developed tuberculosis. Incidence of tuberculosis was calculated to be 733 per 100,000 patient years and occurred after a mean disease duration of 3.0 ± 4.1 years. Extrapulmonary tuberculosis (n = 37) was commoner than pulmonary tuberculosis (n =11). Most common radiological pattern in pulmonary tuberculosis was miliary and musculoskeletal TB was most common extrapulmonary TB. A microbiological diagnosis was obtained in 52.1% patients. Male gender was associated with higher risk of tuberculosis [OR 3.30 (1.55-7.05)]. Mortality was 14.5% and all patients who died had either disseminated (n = 5) or central nervous system (CNS) tuberculosis (n = 2).
CONCLUSION: Incidence of tuberculosis in SLE is higher than general population and is associated with different phenotype and higher mortality. Male gender was associated with increased risk of tuberculosis in SLE.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  SLE; Systemic lupus erythematosus; Tuberculosis

Mesh:

Substances:

Year:  2021        PMID: 34191047     DOI: 10.1007/s00296-021-04933-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  5 in total

1.  Clinical characteristics of 110 miliary tuberculosis patients from a low HIV prevalence country.

Authors:  S F Hussain; M Irfan; M Abbasi; S S Anwer; S Davidson; R Haqqee; J A Khan; M Islam
Journal:  Int J Tuberc Lung Dis       Date:  2004-04       Impact factor: 2.373

Review 2.  Extrapulmonary tuberculosis.

Authors:  S K Sharma; A Mohan
Journal:  Indian J Med Res       Date:  2004-10       Impact factor: 2.375

3.  Isolated tuberculous arthritis of the ankle: a case report and review of the literature.

Authors:  K Natsis; D Grammatikopoulou; P Kokkinos; E Fouka; T Totlis
Journal:  Hippokratia       Date:  2017 Apr-Jun       Impact factor: 0.471

4.  Infections in Systemic Lupus Erythematosus.

Authors:  Anjali G Rajadhyaksha; Kunal Jobanputra
Journal:  J Assoc Physicians India       Date:  2020-05

5.  Tuberculosis case fatality in India: a systematic review and meta-analysis.

Authors:  Sophie Huddart; Anita Svadzian; Vaidehi Nafade; Srinath Satyanarayana; Madhukar Pai
Journal:  BMJ Glob Health       Date:  2020-01-20
  5 in total
  1 in total

1.  Incidence and prevalence of tuberculosis in systemic lupus erythematosus patients: A systematic review and meta-analysis.

Authors:  Qian Wu; Yang Liu; Wei Wang; Yu Zhang; Kui Liu; Song-Hua Chen; Bin Chen
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.